Literature DB >> 4010791

Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

R Niddam, S Arbilla, B Scatton, T Dennis, S Z Langer.   

Abstract

The release of endogenous dopamine evoked by electrical stimulation or by exposure to (+)-amphetamine (10 microM) was determined in superfused striatal slices of the rat. The spontaneous and the electrically-evoked release of dopamine were significantly increased in the presence of nomifensine (10 microM). After reserpine pretreatment (5 mg/kg, s.c., 24 h), the striatal dopamine content was reduced by about 90%. Exposure to 10 microM (+)-amphetamine during 2 min released similar amounts of dopamine from striatal slices of untreated or reserpine pretreated rats. Similar results were obtained when monoamine oxidase activity was inhibited in vivo with pargyline. Pretreatment with reserpine does not modify the (+)-amphetamine-induced release of dopamine, in spite of the marked reduction of the striatal dopamine content. These results provide direct evidence for the view that (+)-amphetamine releases dopamine from a special, reserpine-resistant pool of newly synthetized transmitter.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010791     DOI: 10.1007/bf00501200

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Effect of divalent cations of the amphetamine-induced stimulation of [3H]catechol synthesis in the striatum.

Authors:  N J Uretsky; L Kamal; S R Snodgrass
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

2.  Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.

Authors:  J C Miller; A J Friedhoff
Journal:  Biochem Pharmacol       Date:  1979-03-01       Impact factor: 5.858

3.  The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs.

Authors:  J E Thornburg; K E Moore
Journal:  Neuropharmacology       Date:  1973-09       Impact factor: 5.250

4.  Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

5.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

Review 6.  The actions of amphetamine on neurotransmitters: a brief review.

Authors:  K E Moore
Journal:  Biol Psychiatry       Date:  1977-06       Impact factor: 13.382

7.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

8.  Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.

Authors:  L A Kamal; S Arbilla; A M Galzin; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1983-11       Impact factor: 4.030

9.  Determination of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in rat and human brain and biological fluids by reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  L Semerdjian-Rouquier; L Bossi; B Scatton
Journal:  J Chromatogr       Date:  1981-11-20

10.  Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum. Effects on 3H-acetylcholine release.

Authors:  R Cantrill; S Arbilla; B Zivkovic; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

View more
  16 in total

1.  Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.

Authors:  A J Azzaro; J Liccione; J Lucci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.

Authors:  M Watanabe; M Kinuya; G Mamiya; T Tatsunuma; M Nagayoshi; T Matsutani; Y Tsukada
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

3.  MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.

Authors:  Sanders A McDougall; Matthew G Apodaca; Ginny I Park; Angie Teran; Timothy J Baum; Nazaret R Montejano
Journal:  Psychopharmacology (Berl)       Date:  2020-05-22       Impact factor: 4.530

4.  Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.

Authors:  J A García-Sevilla; J K Zubieta
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

5.  The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.

Authors:  T N Robinson; R J De Souza; A J Cross; A R Green
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

6.  An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.

Authors:  A Adell; G S Sarna; P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.

Authors:  D E Dluzen; F T Kratko
Journal:  J Neural Transm Gen Sect       Date:  1992

8.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

9.  Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.

Authors:  B Nurse; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1988-05       Impact factor: 3.996

10.  Comparison between radiolabelled and endogenous dopamine release from rat striatal slices: effects of electrical field stimulation and regulation by D2-autoreceptors.

Authors:  H Herdon; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.